Cyclo Therapeutics : Management Change - Form 8-K -Today at 08:41 am

ctdh20230820_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 8-K


CURRENT REPORT
Pursuant to Section 13...

Related Keywords

Gainesville ,Florida ,United States ,Nevada ,Washington ,Vivien Wong ,Rafael Holdings Inc ,Commission File Number ,Nasdaq Stock Market ,Company Definitive Proxy Statement ,Mississippi University For Women ,Securities Exchange ,Us Securities Exchange ,Exchange Commission On ,Research Development ,Southern Illinois University At Carbondale ,Burke Neurological Institute Of Weill Cornell Medicine ,Cyclo Therapeutics Inc ,Progenics Pharmaceuticals Inc ,Board Of Directors Cyclo Therapeutics Inc ,Jurisdiction Of Incorporation Or Organization ,Company Current Report On Form ,Neurocures Ny Inc ,University Of Maryland School Medicine ,Bioscience Task ,Westchester County Economic Development ,Securities Exchange Act ,Principal Executive Offices ,Securities Act ,Exchange Act ,Common Stock ,Certain Officers ,Compensatory Arrangements ,Effective August ,Cyclo Therapeutics ,Burke Neurological Institute ,Weill Cornell Medicine ,Bioscience Task Force ,Westchester County Economic ,Progenics Pharmaceuticals ,Executive Vice President ,Maryland School ,Southern Illinois University ,Mississippi University ,Definitive Proxy Statement ,Exchange Commission ,Rafael Holdings ,Regulations K ,Purchase Agreement ,Current Report ,Page Interactive Data File ,Markets ,